UBS Group’s Arcellx ACLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-194,709
| Closed | -$22.4M | – | 10402 |
|
|
2026
Q1 | $22.4M | Sell |
194,709
-121,903
| -39% | -$10.8M | ﹤0.01% | 2473 |
|
|
2025
Q4 | $20.6M | Buy |
316,612
+127,236
| +67% | +$10.2M | ﹤0.01% | 2563 |
|
|
2025
Q3 | $15.5M | Buy |
189,376
+40,459
| +27% | +$2.91M | ﹤0.01% | 2846 |
|
|
2025
Q2 | $9.81M | Sell |
148,917
-60,655
| -29% | -$3.78M | ﹤0.01% | 3095 |
|
|
2025
Q1 | $13.7M | Buy |
209,572
+2,033
| +1% | +$138K | ﹤0.01% | 2725 |
|
|
2024
Q4 | $15.9M | Buy |
207,539
+150,176
| +262% | +$13M | ﹤0.01% | 2578 |
|
|
2024
Q3 | $4.79M | Sell |
57,363
-6,214
| -10% | -$414K | ﹤0.01% | 3116 |
|
|
2024
Q2 | $3.51M | Sell |
63,577
-39,904
| -39% | -$2.17M | ﹤0.01% | 3195 |
|
|
2024
Q1 | $7.2M | Buy |
103,481
+6,436
| +7% | +$408K | ﹤0.01% | 2580 |
|
|
2023
Q4 | $5.39M | Buy |
97,045
+47,613
| +96% | +$2.15M | ﹤0.01% | 2709 |
|
|
2023
Q3 | $1.77M | Sell |
49,432
-72,075
| -59% | -$2.48M | ﹤0.01% | 3557 |
|
|
2023
Q2 | $3.84M | Buy |
121,507
+120,515
| +12,149% | +$4.61M | ﹤0.01% | 2841 |
|
|
2023
Q1 | $30.6K | Sell |
992
-1,449
| -59% | -$44K | ﹤0.01% | 6784 |
|
|
2022
Q4 | $75.6K | Sell |
2,441
-184,236
| -99% | -$4.23M | ﹤0.01% | 6364 |
|
|
2022
Q3 | $3.5M | Sell |
186,677
-9,980
| -5% | -$191K | ﹤0.01% | 2666 |
|
|
2022
Q2 | $3.56M | Sell |
196,657
-29,604
| -13% | -$382K | ﹤0.01% | 2660 |
|
|
2022
Q1 | $3.17M | Buy |
+226,261
| New | +$3.78M | ﹤0.01% | 3008 |
|
Other funds holding ACLX
UBS Group's ACLX Position: Q2 2026 in Review
UBS Group sold out of Arcellx (ACLX) in Q2 2026, closing a stake of 194,709 shares — an estimated $22.4M sold.
UBS Group first reported a position in ACLX in Q1 2022 and held it in 17 quarters. The position peaked at $22.4M in Q1 2026. 2 funds tracked by Wall St. Rank hold ACLX as of Q2 2026.
- UBS Group reported no remaining Arcellx position as of Q2 2026 after selling out during the quarter.
- UBS Group sold 194,709 Arcellx shares in Q2 2026, an estimated $22.4M.
- UBS Group first reported a position in Arcellx in Q1 2022 and held it in 17 quarters.
- UBS Group's Arcellx position peaked at $22.4M in Q1 2026.
- 2 funds tracked by Wall St. Rank held Arcellx as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.